All Stories

  1. PCSK9 Inhibitors: From Nature’s Lessons to Clinical Utility

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, July 2020, Bentham Science Publishers

    Professor Naresh Ranjith, Professor Viren Rambiritch, Frederick Raal

  2. Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects

    Article • Clinical Pharmacology Advances and Applications, September 2016, Dove Medical Press

    Professor Viren Rambiritch, Professor Goonaseelan Pillai

  3. Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects

    Article • Clinical Pharmacology Advances and Applications, July 2016, Dove Medical Press

    Professor Viren Rambiritch, Professor Goonaseelan Pillai